🇺🇸 FDA
Pipeline program

Losartan

Losartan_IgA_2014

Phase 3 small_molecule completed

Quick answer

Losartan for Glomerulonephritis, IGA is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Glomerulonephritis, IGA
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials